Cytotechnology

, Volume 70, Issue 1, pp 415–421 | Cite as

Ghrelin accelerates the cartilagic differentiation of rabbit mesenchymal stem cells through the ERK1/2 pathway

Original Article
  • 64 Downloads

Abstract

Mesenchymal stem cells (MSCs) can differentiate into chondroblasts, adipocytes, or cartilage under appropriate stimulation. Identifying a mechanism triggering the differentiation of MSCs into cartilage may help develop novel therapeutic approaches for treating heterotopic ossification, the pathological formation of lamellar bone in soft tissue outside the skeleton that can lead to debilitating immobility. Ghrelin, an endogenous ligand for the growth hormone secretagogue receptor, stimulates growth hormone secretion, and has both orexigenic and adipogenic effects. This study sought to understand the potential involvement of the ERK1/2 signaling pathway in the ghrelin-induced growth of rat MSCs (rMSCs). We applied various concentrations of ghrelin to cultured rMSCs by observing the changes in the phosphorylation state of ERK1/2, p38, JNK as well as the type II collagen expression levels by western blot. The highest expression level for both type II collagen was obtained with 600 ng/mL ghrelin at 24 h. We found that the ghrelin-induced differentiation of rMSCs into cartilage was promoted primarily by the ERK1/2 pathway. Our study suggests that ghrelin induced differentiation of rMSCs into cartilage primarily through the ERK1/2 pathway.

Keywords

rMSCs MAPK Ghrelin Cartilage differentiation ERK1/2 

Notes

Acknowledgement

This work was supported by Inner Mongolia Natural Science Foundation (No. 2017BS0813).

References

  1. Fromigué O, Marie PJ, Lomri A (1998) Bone morphogenetic protein-2 and transforming growth factor-β2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 68:411–426CrossRefGoogle Scholar
  2. Gao M, Yang J, Wei R, Liu G, Zhang L, Wang H, Wang G, Gao H, Chen G, Hong T (2013) Ghrelin induces cardiac lineage differentiation of human embryonic stem cells through ERK1/2 pathway. Int J Cardiol 167:2724–2733CrossRefGoogle Scholar
  3. Kara M, Ekiz T, Ozturk GT, Onat SS, Ozcakar L (2015) Heterotopic ossification and peripheral nerve entrapment: ultrasound is a must-use imaging modality. Pain Med 16:1643–1644CrossRefGoogle Scholar
  4. Moon M, Kim S, Hwang L, Park S (2009) Ghrelin regulates hippocampal neurogenesis in adult mice. Endocr J 56:525–531CrossRefGoogle Scholar
  5. Qiu W, Chen N, Zhang Q, Zhuo L, Wang X, Wang D, Jin H (2014) Resistin increases platelet P-selectin levels via p38 MAPK signal pathway. Diab Vasc Dis Res 11:121–124CrossRefGoogle Scholar
  6. Rambhojan C, Bouaziz-Amar E, Larifla L, Deloumeaux J, Clepier J, Plumasseau J, Lacorte JM, Foucan L (2015) Ghrelin, adipokines, metabolic factors in relation with weight status in school-children and results of a 1-year lifestyle intervention program. Nutr Metab (Lond) 12:43CrossRefGoogle Scholar
  7. Rodriguez-Pena JM, Diez-Muniz S, Bermejo C, Nombela C, Arroyo J (2013) Activation of the yeast cell wall integrity MAPK pathway by zymolyase depends on protease and glucanase activities and requires the mucin-like protein Hkr1 but not Msb2. FEBS Lett 587:3675–3680CrossRefGoogle Scholar
  8. Shi L, Du X, Jiang H, Xie J (2016) Ghrelin and neurodegenerative disorders—a review. Mol Neurobiol 54:1144–1155CrossRefGoogle Scholar
  9. Smith MP, Sanchez-Laorden B, O'Brien K, Brunton H, Ferguson J, Young H, Dhomen N, Flaherty KT, Frederick DT, Cooper ZA et al (2014) The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFalpha. Cancer Discov 4:1214–1229CrossRefGoogle Scholar
  10. St-Onge V, Watts A, Abizaid A (2016) Ghrelin enhances cue-induced bar pressing for high fat food. Horm Behav 78:141–149CrossRefGoogle Scholar
  11. Tack J, Corsetti M (2015) Ghrelin agonists as emerging prokinetic agents. Clin Gastroenterol Hepatol 13:2320–2322CrossRefGoogle Scholar
  12. Tena-Sempere M (2005) Ghrelin: novel regulator of gonadal function. J Endocrinol Invest 28:26–29Google Scholar
  13. Urosevic J, Nebreda AR, Gomis RR (2014) MAPK signaling control of colon cancer metastasis. Cell Cycle 13:2641–2642CrossRefGoogle Scholar
  14. Wu W, Fan X, Yu Y, Wang Y (2015) Maternal serum ratio of ghrelin to obestatin decreased in preeclampsia. Pregnancy Hypertens 5:263–266CrossRefGoogle Scholar
  15. Xie Y, Peng Z, Shi M, Ji M, Guo H, Shi H (2014) Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatinresistant ovarian cancer. Mol Med Rep 10:2346–2350CrossRefGoogle Scholar
  16. Xu G, Li Y, An W, Zhang W (2008) Ghrelin and cell differentiation. Acta Biochim Biophys Sin (Shanghai) 40:841–847CrossRefGoogle Scholar
  17. Ye N, Jiang D (2015) Ghrelin accelerates the growth and osteogenic differentiation of rabbit mesenchymal stem cells through the ERK1/2 pathway. BMC Biotechnol 15:51CrossRefGoogle Scholar
  18. Yin Q, Zhou YY, Wang P, Ma LI, Li P, Wang XG, She CH, Li WL (2016) CD44 promotes the migration of bone marrow-derived mesenchymal stem cells toward glioma. Oncol Lett 11:2353–2358CrossRefGoogle Scholar
  19. Zhang C, Shi J, Mao SY, Xu YS, Zhang D, Feng LY, Zhang B, Yan YY, Wang SC, Pan JP et al (2015) Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT-737. J Cell Mol Med 19:408–417CrossRefGoogle Scholar
  20. Zhang R, Lu M, Zhang Z, Tian X, Wang S, Lv D (2016) Resveratrol reverses P-glycoprotein-mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF-kappaB and p38 MAPK signaling pathways. Oncol Lett 12:4147–4154CrossRefGoogle Scholar
  21. Zhao X, Hwang NS, Bichara DA, Saris DB, Malda J, Vacanti JP, Pomerantseva I, Sundback CA, Langer R, Anderson DG, Randolph MA (2016a) Chondrogenesis by bone marrow-derived mesenchymal stem cells grown in chondrocyte-conditioned medium for auricular reconstruction. J Tissue Eng Regen Med 11:121–125Google Scholar
  22. Zhao Y, Wang X, Dong P, Xu Q, Ma Z, Mu Q, Sun X, Jiang Z (2016b) Bone marrow derived mesenchymal stem cells alleviated brain injury via down-regulation of interleukin-1β in focal cerebral ischemic rats. Am J Transl Res 8:1541–1550Google Scholar
  23. Zheng Y, Cai W, Zhou S, Xu L, Jiang C (2016) Protective effect of bone marrow derived mesenchymal stem cells in lipopolysaccharide-induced acute lung injury mediated by claudin-4 in a rat model. Am J Transl Res 8:3769–3779Google Scholar
  24. Zhou J, Carter BZ, Andreeff M (2016a) Bone-marrow-derived mesenchymal stem cells inhibit gastric aspiration lung injury and inflammation in rats. J Cell Mol Med 20:1706–1717CrossRefGoogle Scholar
  25. Zhou HS, Carter BZ, Andreeff M (2016b) Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang. Cancer Biol Med 13:248–259CrossRefGoogle Scholar
  26. Zhu S, Zhang T, Sun C, Yu A, Qi B, Cheng H (2013) Bone marrow mesenchymal stem cells combined with calcium alginate gel modified by hTGF-beta1 for the construction of tissue-engineered cartilage in three-dimensional conditions. Exp Ther Med 5:95–101CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2017

Authors and Affiliations

  1. 1.Department of Cervical SurgeryThe Second Affiliated Hospital of Inner Mongolia Medical UniversityHohhotChina

Personalised recommendations